Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.
Saved in:
| Title: | Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy. |
|---|---|
| Authors: | Di Pastena, Fiorella1 (AUTHOR), Pond, Gregory2,3 (AUTHOR), Tsakiridis, Evangelia E.1 (AUTHOR), Gouveia, Andre2,4 (AUTHOR), Ahmadi, Elham1,2,5 (AUTHOR), Biziotis, Olga-Demetra1,2,5 (AUTHOR), Ali, Amr1,2,5 (AUTHOR), Swaminath, Anand2,4 (AUTHOR), Okawara, Gordon2,4 (AUTHOR), Ellis, Peter M.2 (AUTHOR), Abdulkarim, Bassam6 (AUTHOR), Ahmed, Naseer7 (AUTHOR), Robinson, Andrew8 (AUTHOR), Roa, Wilson9 (AUTHOR), Valdes, Mario10 (AUTHOR), Kavsak, Peter11 (AUTHOR), Wierzbicki, Marcin12 (AUTHOR), Wright, James2,3,4 (AUTHOR), Steinberg, Gregory1,13 (AUTHOR), Tsakiridis, Theodoros1,2,3,4,5 (AUTHOR) theos.tsakiridis@mcmaster.ca |
| Source: | Radiation Oncology. 11/7/2024, Vol. 19 Issue 1, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
